Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Metabolic and Nutritional Responses to Acute High-intensity Interval Exercise Performed Under Hypoxic vs. Normoxic Conditions at Matched External Workload in Adults With Overweight and Obesity. (HYPOXHIIT)

Comparison of HIIT Exercise Under Hypoxic and Normoxic Conditions in Adults With Overweight or Obesity: Impact on Oxygen Consumption, Carbohydrate and Lipid Substrate Utilization, and Appetite During Recovery.

Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, HIIT (High-Intensity Interval Training) workouts are now recognized as fun and effective programs for promoting fat loss. To date, in overweight or obese individuals, only two studies mention the benefits of HIIT performed under hypoxia for modulating body composition, and more specifically, reducing the amount of adipose tissue. These studies hypothesize an increased energy expenditure under hypoxia associated with a transient loss of appetite. In order, to further investigate the adaptations following HIIT under hypoxia versus normoxia, we propose to compare, in acute conditions, two HIIT sessions (simulated hypoxia-normobaric vs. normoxia) in overweight or obese subjects. The objective of this assessment is to compare, during exercise and recovery (+2h), oxygen consumption, corresponding energy expenditure, and carbohydrate and lipid utilization in hypoxic versus normoxic conditions. Given the potential influence of hypoxia on appetite, spontaneous food intake and energy expenditure post-24h will also be measured. Finally, since pleasure and perceived exertion are key parameters in adherence to an adapted physical activity (APA) program, these two concepts will also be evaluated through the subjects' experiences.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Obesity management involves lifestyle and dietary measures that include appropriate nutrition and increased physical activity (PA). Among the various PA options available, High-intensity interval training (HIIT) is now recognized as a well-tolerated, safe, and effective exercise modality for improving body composition. In 2016, our pioneering study demonstrated that HIIT is more effective than moderate-intensity continuous training (MICT) in inducing abdominal fat loss in postmenopausal women. A subsequent meta-analysis, conducted by our team in 2018 and encompassing 39 articles involving 617 participants, confirmed the significant effects of HIIT on reducing total and abdominal fat mass in overweight or obese individuals More recently, our work has shown significant results from HIIT + resistance training or HIIT cycling vs. running on improving body composition, and more specifically on reducing abdominal and visceral fat mass, in overweight or obese subjects.

With a focus on performance, HIIT has been combined with simulated hypoxia to maximize training adaptations, particularly to improve cardiovascular, respiratory, circulatory, hematological, and metabolic capacities at the muscular level. Live Low Train High (LLTH) allows athletes to maintain normoxia while being exposed to acute periods of hypoxia during training via hypoxic chambers (simulated altitude). More recently, research has explored the effects of HIIT under hypoxic conditions in patients with metabolic disorders and/or physical deconditioning, focusing primarily on cardiovascular and ventilatory adaptations. To date, in overweight or obese individuals, only three studies investigated the benefit of HIIT under simulated hypoxia for modulating body composition, and more specifically for reducing total or abdominal fat. These studies generally hypothesize a higher energy expenditure during hypoxia, associated with a transient loss of appetite that may be linked to hormonal disturbances, central nervous system adaptability, or metabolic flexibility altering hunger and satiety signals.

In parallel with these hypotheses, hypoxia stimulates HIF-1 production, thus promoting a shift from oxidative metabolism to glycolysis. At the same external mechanical load, the increased use of carbohydrates via glycolysis, combined with increased cardiovascular stress, should promote, during the recovery phase, greater oxygen consumption and lipid oxidation following a hypoxic session. To date, no study has yet evaluated these hypotheses by comparing these parameters following two acute HIIT sessions performed under normoxia or hypoxia.

The aim is to compare the influence of these two sessions on oxygen consumption, the corresponding energy expenditure, and carbohydrate and lipid utilization during recovery (+2h). Given the potential influence of hypoxia on appetite, food intake and spontaneous energy expenditure post-24h will also be measured. Finally, since enjoyment and perceived exertion are crucial parameters for adherence to an adapted physical activity (APA) program, these two concepts will also be assessed through the participants' experiences.

The authors propose the following hypotheses:

Main hypothesis:

  1. Lipid oxidation (g/min) during recovery (+2h) will be higher post-hypoxic session.

    Secondary hypotheses:

  2. Oxygen consumption and energy expenditure will be increased during post-hypoxic session recovery.

4/ Energy intake from the post-exercise meal may be lower post-hypoxic condition.

5/ The effort will be perceived as slightly more difficult in hypoxia due to increased cardiovascular demand.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

18

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Allier
      • Bellerive-sur-Allier, Allier, Francia, 03321
        • CREPS Auvergne Rhône-Alpes / Vichy

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

- overweight or obesity (BMI between 25 kg/m2 and 35 kg/m2)

Exclusion Criteria:

  • medical contraindications to intense physical activity
  • taking ß-blocker
  • diabete
  • women taking hormonal replacement therapy

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: High Intensity Interval Exercise - Normoxia
HIIE in normoxia
Cycling HIIE in Normoxia: 60 x [8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax]
Sperimentale: High Intensity Interval Exercise - Hypoxia
HIIE in hypoxia
Cycling HIIE in Hypoxia (FiO2: 15%): 60 x [8 seconds at a power equivalent to 80-85% of HRmax followed by 12 seconds of active recovery at a power equivalent to 40% of HRmax]

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Lipid oxidation after the exercise session (nromoxia and hypoxia).
Lasso di tempo: Measurement during two hours after the end of the exercise
Determination of lipid and carbohydrate oxidation after the exercise (HIIE normoxia and hypoxia). Lipid aoxidation is measured from oxygen and carbon dioxide consumption (Metamax 3D Cortex).
Measurement during two hours after the end of the exercise

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Oxygen consumption during the recovery period
Lasso di tempo: Two hours after the end of the exercise
Determination of oxygen consumption 2 hours after the exercise session (HIIE normoxia and hypoxia). Determination from Metamax (3D Cortex).
Two hours after the end of the exercise
Energy intakes 24 hours after the exercise
Lasso di tempo: 24 hours post exercise
Evaluation of energy intakes after the exercise session (HIIE normoxia and HIIE hypoxia) during 24 hours (from questionnaires)
24 hours post exercise
Appetite
Lasso di tempo: Before exercise and after exercise (+0 min, +60 min, and +120 min).
Feelings of appetite are measured using a visual appetite scale immediately before and after exercise (+0 min, +60 min, and +120 min).
Before exercise and after exercise (+0 min, +60 min, and +120 min).

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 novembre 2024

Completamento primario (Effettivo)

1 settembre 2026

Completamento dello studio (Effettivo)

1 settembre 2026

Date di iscrizione allo studio

Primo inviato

5 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 settembre 2026

Primo Inserito (Effettivo)

11 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

5 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB00012476-2024-23-09-342

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .